TY - JOUR T1 - Detection and Segmentation of Lesion Areas in Chest CT Scans For The Prediction of COVID-19 JF - medRxiv DO - 10.1101/2020.10.23.20218461 SP - 2020.10.23.20218461 AU - Aram Ter-Sarkisov Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/27/2020.10.23.20218461.abstract N2 - In this paper we compare the models for the detection and segmentation of Ground Glass Opacity and Consolidation in chest CT scans. These lesion areas are often associated both with common pneumonia and COVID-19. We train a Mask R-CNN model to segment these areas with high accuracy using three approaches: merging masks for these lesions into one, deleting the mask for Consolidation, and using both masks separately. The best model achieves the mean average precision of 44.68% using MS COCO criterion for instance segmentation across all accuracy thresholds. The classification model, COVID-CT-Mask-Net, which learns to predict the presence of COVID-19 vs common pneumonia vs control, achieves the 93.88% COVID-19 sensitivity, 95.64% overall accuracy, 95.06% common pneumonia sensitivity and 96.91% true negative rate on the COVIDx-CT test split (21192 CT scans) using a small fraction of the training data. We also analyze the effect of Non-Maximum Suppression of overlapping object predictions, both on the segmentation and classification accuracy. The full source code, models and pretrained weights are available on https://github.com/AlexTS1980/COVID-CT-Mask-Net.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding involvedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data, algorithms, code, pretrained weights, etc are publicly available. https://github.com/AlexTS1980/COVID-CT-Mask-Net ER -